← All trials
NCT04831684
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2022
- Primary completion
- Apr 15, 2026
- Completion date
- Apr 22, 2026
- First posted
- Apr 5, 2021
- Last posted
- Nov 22, 2021
- Enrollment
- 90
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Medical University of South CarolinaLead sponsor
- National Institutes of Health (NIH)Collaborator
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)Collaborator
- Medical University of South CarolinaReponsible party - principal investigator
- Medical University of South CarolinaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.